Human Embryonic Stem Cells Market

Human embryonic stem cell: also known as a human pluripotent stem cell, one of the "cells that are self-replicating, are derived from human embryos or human fetal tissue, and are known to develop into cells and tissues of the three primary germ layers.

Human Embryonic Stem Cells Market contains market size and forecasts of Human Embryonic Stem Cells (HESC) in global, including the following market information:

• Global Human Embryonic Stem Cells (HESC) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Human Embryonic Stem Cells (HESC) Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Human Embryonic Stem Cells (HESC) companies in 2021 (%)

The global Human Embryonic Stem Cells (HESC) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Totipotent Stem Cells Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Embryonic Stem Cells (HESC) include ESI BIO, Thermo Fisher, BioTime, MilliporeSigma (Merck), BD Biosciences, Astellas Institute of Regenerative Medicine, Asterias Biotherapeutics, PerkinElmer and Takara Bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Human Embryonic Stem Cells (HESC) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Embryonic Stem Cells (HESC) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Embryonic Stem Cells (HESC) Market Segment Percentages, by Type, 2021 (%)

• Totipotent Stem Cells
• Pluripotent Stem Cells
• Unipotent Stem Cells

Global Human Embryonic Stem Cells (HESC) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Embryonic Stem Cells (HESC) Market Segment Percentages, by Application, 2021 (%)

• Research
• Clinical Trials
• Others

Global Human Embryonic Stem Cells (HESC) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Embryonic Stem Cells (HESC) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Human Embryonic Stem Cells (HESC) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Human Embryonic Stem Cells (HESC) revenues share in global market, 2021 (%)
• Key companies Human Embryonic Stem Cells (HESC) sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Human Embryonic Stem Cells (HESC) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ESI BIO
• Thermo Fisher
• BioTime
• MilliporeSigma (Merck)
• BD Biosciences
• Astellas Institute of Regenerative Medicine
• Asterias Biotherapeutics
• PerkinElmer
• Takara Bio
• Fujifilm Cellular Dynamics
• Reliance Life Sciences
• R&D Systems (Biotrchne)
• STEMCELL Technologies
• TATAA Biocenter
• UK Stem Cell Bank
• Viacyte, Inc.